Results of the sampling and testing programme 2010

This report contains information on the management and the outcomes of the Sampling and Testing Programme for the year 2010. These programmes are organised and co-ordinated every year by the European Medicines Agency (EMA), in order to comply with its legal obligations under Article 57(r)1 of Regulation (EC) 726/2004. The main aim of the programmes is to verify that the centrally authorised medicinal products on the market comply with their authorised quality specifications.

• Primary Source